Lumexa Imaging Reports Strong Q4 & FY25 Results, Significant Debt Reduction, Reiterates 2026 Guidance

summarizeSummary

Lumexa Imaging announced robust preliminary Q4 and full year 2025 financial results, highlighted by strong Adjusted EBITDA growth, significant debt reduction, and reiterated positive 2026 guidance.

check_boxKey Events

• Strong Financial Performance

  Reported Q4 2025 consolidated revenues of $267.7 million (up 7.9%) and Adjusted EBITDA of $63.8 million (up 18.6%). Full year 2025 consolidated revenues reached $1.023 billion (up 7.8%) and Adjusted EBITDA was $230.2 million (up 14.6%).

• Significant Leverage Reduction

  Achieved a two-turn reduction in leverage from 5.5 times to 3.5 times, resulting in over $50 million in annual cash savings.

• Reduced Full Year Net Loss

  Full year 2025 net loss significantly decreased to $47.1 million from $94.1 million in 2024.

• Reiterated 2026 Guidance

  Reaffirmed full year 2026 outlook, expecting consolidated revenues between $1.045 billion and $1.097 billion and Adjusted EBITDA between $234 million and $242 million, along with Adjusted EPS of $0.71 to $0.77 per share.

auto_awesomeAnalysis

This 8-K formally discloses Lumexa Imaging's preliminary Q4 and full year 2025 financial results, which were previously announced via press release. The results indicate strong operational momentum, particularly in Adjusted EBITDA growth and advanced imaging volumes. The most impactful news is the substantial reduction in leverage, which significantly strengthens the company's balance sheet and provides considerable annual cash savings. While the company still reported a net loss, the year-over-year improvement and the positive Adjusted EBITDA trends are encouraging. The reiteration of 2026 guidance, projecting continued growth, reinforces a positive outlook for investors. This filing provides critical updates on the company's financial health and future trajectory.